Exploration of the Optimal Desmopressin Treatment in Children With Monosymptomatic Nocturnal Enuresis: Evidence From a Chinese Cohort

Objectives: Nocturnal enuresis (NE) is a common pediatric condition, and desmopressin (dDAVP) is a first-line therapy for NE. The standard initial dosage of dDAVP is 0. 2 mg/day, and most guidelines recommend that the dose should be increased at 0.2 mg increments until dryness is achieved or to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiaojiao, Ni, Jiajia, Miao, Qianfan, Wang, Chunyan, Lin, Fang, Cao, Qi, Guo, Wei, Yang, Xue, Ji, Xiaolu, Zhai, Yihui, Bi, Yunli, Shen, Qian, Xu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868531/
https://www.ncbi.nlm.nih.gov/pubmed/33569362
http://dx.doi.org/10.3389/fped.2020.626083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868531/
https://www.ncbi.nlm.nih.gov/pubmed/33569362
http://dx.doi.org/10.3389/fped.2020.626083

Ejemplares similares